DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 146 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $2,188,000 | +121.0% | 58,619 | +50.4% | 0.34% | +54.3% |
Q2 2020 | $990,000 | -21.8% | 38,983 | -43.4% | 0.22% | -44.3% |
Q1 2020 | $1,266,000 | -66.4% | 68,915 | -59.7% | 0.39% | -52.6% |
Q4 2019 | $3,769,000 | +889.2% | 171,088 | +379.6% | 0.83% | +704.9% |
Q4 2018 | $381,000 | -47.2% | 35,673 | -24.6% | 0.10% | -3.7% |
Q3 2018 | $722,000 | +24.7% | 47,286 | 0.0% | 0.11% | +17.6% |
Q2 2018 | $579,000 | +28.1% | 47,286 | 0.0% | 0.09% | +21.3% |
Q1 2018 | $452,000 | -22.2% | 47,286 | -26.5% | 0.08% | -27.9% |
Q4 2017 | $581,000 | – | 64,340 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |